Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1141251

	registered interest
	date	23/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when a long-term workforce plan which sets out the number of staff required to meet the current and future needs of cancer patients will be published.
	tabling member constituency	Denton and Reddish
	tabling member printed	Andrew Gwynne
	uin	280964
	answer	answer is ministerial correction date of answer 05/08/2019 answer text <p>The interim NHS People Plan, published on 3 June 2019, puts the workforce at the heart of the National Health Service and will ensure we have the staff needed to deliver high quality care. A final People Plan will be published soon after the conclusion of the 2019 Spending Review.</p><p>Phase 1 of the Cancer Workforce Plan for England, published in December 2017 by Health Education England (HEE), set out plans to expand capacity and skills in the cancer workforce, including targeting additional training support for seven priority professions which are key to cancer prevention, diagnosis and treatment, such as clinical radiology, histopathology, oncology and diagnostic and therapeutic radiography.</p><p>HEE will now work with NHS England and NHS Improvement to understand the longer-term workforce implications of further development of cancer services. This work will inform the final People Plan.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 05/08/2019 11:30:43 answering member 4380 label Biography information for Jo Churchill
	tabling member	1506 label Biography information for Andrew Gwynne

1141282

	registered interest
	date	23/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Electronic Cigarettes: Health Hazards
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of the increased numbers of people vaping on (a) nicotine addiction, (b) incidences of increased blood pressure and (c) heart attack rates.
	tabling member constituency	North East Hampshire
	tabling member printed	Mr Ranil Jayawardena
	uin	281030
	answer	answer is ministerial correction date of answer 05/08/2019 answer text <p>Public Health England (PHE) has published a series of reports on electronic cigarettes including the effects of vaping on health. The reports are available to view at the following link:</p><p><a href="https://www.gov.uk/government/collections/e-cigarettes-and-vaping-policy-regulation-and-guidance" target="_blank">https://www.gov.uk/government/collections/e-cigarettes-and-vaping-policy-regulation-and-guidance</a></p><p>While nicotine can contribute to raised blood pressure and cardiovascular risk, it is tar and carbon monoxide, which are the major sources of cardiovascular risk in cigarette smoke, producing nicotine vapour from a solution rather than by burning tobacco means that electronic cigarette vapour is free from almost all the toxic chemicals that accompany nicotine in cigarette smoke.</p><p>The Office for National Statistics has recorded the numbers of people using e-cigarettes since 2014 and the combined number of people using e-cigarettes and smoking has not increased since then. The proportion of people who smoke has decreased substantially in the same period.</p><p>PHE encourages people who both vape and smoke to stop smoking completely, because this greatly reduces health risks.</p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 05/08/2019 11:25:52 answering member 4380 label Biography information for Jo Churchill
	tabling member	4498 label Biography information for Mr Ranil Jayawardena

1141283

	registered interest
	date	23/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Electronic Cigarettes
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will bring forward legislative proposals to ban e-cigarettes wherever the smoking ban is in place. .
	tabling member constituency	North East Hampshire
	tabling member printed	Mr Ranil Jayawardena
	uin	281031
	answer	answer is ministerial correction date of answer 05/08/2019 answer text <p>The Government believes in proportionate regulation of e-cigarettes, recognising that they are not risk-free. Through the European Union Tobacco Products Directive 2014/40/EU (TPD), transposed into United Kingdom law by the UK Tobacco and Related Products Regulations 2016 (TRPR), we have introduced measures to regulate e-cigarettes. These measures reduce the risk of harm to children, protect against any risk of renormalisation of tobacco use, provide assurance on relative safety for users, and give businesses legal certainty. This has enabled the UK to implement appropriate standards for products whilst allowing smokers to move to e-cigarettes should they wish.</p><p> </p><p>The Government has made a commitment to review the TRPR by May 2021 to consider its regulatory impact. In addition, as announced in the Tobacco Control Plan the Government will review where the UK’s exit from the European Union offers us opportunities to re-appraise current regulation to ensure this continues to protect the nation’s health.</p><p>The Government has no plans to introduce legislative proposals to ban e-cigarettes, e-cigarette shops or smoking on National Health Service property.</p><p>We continue to support the implementation of smokefree policies across all hospitals in England. The Government’s tobacco control plan for England published in July 2017 reiterates our ambition to achieve smokefree mental health services and NHS estate by 2019/20. The NHS Long Term Plan, published in January 2019, further supports the creation of a Smokefree NHS with the commitment to offering NHS-funded tobacco treatment services to all patients who smoke.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 281032 question first answered 05/08/2019 11:29:19 answering member 4380 label Biography information for Jo Churchill
	tabling member	4498 label Biography information for Mr Ranil Jayawardena

1141284

	registered interest
	date	23/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Hospitals: Electronic Cigarettes
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will bring forward legislative proposals to ban (a) e-cigarette shops and (b) smoking on NHS hospital property.
	tabling member constituency	North East Hampshire
	tabling member printed	Mr Ranil Jayawardena
	uin	281032
	answer	answer is ministerial correction date of answer 05/08/2019 answer text <p>The Government believes in proportionate regulation of e-cigarettes, recognising that they are not risk-free. Through the European Union Tobacco Products Directive 2014/40/EU (TPD), transposed into United Kingdom law by the UK Tobacco and Related Products Regulations 2016 (TRPR), we have introduced measures to regulate e-cigarettes. These measures reduce the risk of harm to children, protect against any risk of renormalisation of tobacco use, provide assurance on relative safety for users, and give businesses legal certainty. This has enabled the UK to implement appropriate standards for products whilst allowing smokers to move to e-cigarettes should they wish.</p><p> </p><p>The Government has made a commitment to review the TRPR by May 2021 to consider its regulatory impact. In addition, as announced in the Tobacco Control Plan the Government will review where the UK’s exit from the European Union offers us opportunities to re-appraise current regulation to ensure this continues to protect the nation’s health.</p><p>The Government has no plans to introduce legislative proposals to ban e-cigarettes, e-cigarette shops or smoking on National Health Service property.</p><p>We continue to support the implementation of smokefree policies across all hospitals in England. The Government’s tobacco control plan for England published in July 2017 reiterates our ambition to achieve smokefree mental health services and NHS estate by 2019/20. The NHS Long Term Plan, published in January 2019, further supports the creation of a Smokefree NHS with the commitment to offering NHS-funded tobacco treatment services to all patients who smoke.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 281031 question first answered 05/08/2019 11:29:19 answering member 4380 label Biography information for Jo Churchill
	tabling member	4498 label Biography information for Mr Ranil Jayawardena

1141336

	registered interest
	date	23/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pharmacy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to increase the number of community pharmacies.
	tabling member constituency	Harborough
	tabling member printed	Neil O'Brien
	uin	281058
	answer	answer is ministerial correction date of answer 05/08/2019 answer text <p>The Government is not actively looking to increase the number of community pharmacies in England.</p><p>Applications to provide National Health Service pharmaceutical services continue to be determined by NHS England and NHS Improvement, informed by the local pharmaceutical needs assessment, which outlines the level of NHS pharmaceutical services provision in a given area, including if there are any gaps or unmet needs.</p><p>In England, access to NHS pharmaceutical services is good. There are over 11,500 community pharmacies, which is 12% more than a decade ago. This coverage means that 80% of the population live within 20 minutes walking distance of a community pharmacy, with more pharmacies in the most deprived areas.</p><p>Maintaining access to NHS pharmaceutical services remains an important priority for the Government. We will continue to maintain the good level of access we have in England through the Pharmacy Access Scheme, which provides additional financial support to pharmacies in areas where there are fewer pharmacies.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 05/08/2019 11:27:19 answering member 4380 label Biography information for Jo Churchill
	tabling member	4679 label Biography information for Neil O'Brien

1141356

	registered interest
	date	23/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Sapropterin
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of whether Kuvan should be assessed through NICE's highly-specialised technology appraisal.
	tabling member constituency	North Durham
	tabling member printed	Mr Kevan Jones
	uin	280943
	answer	answer is ministerial correction date of answer 06/08/2019 answer text <p>Decisions on whether individual medicines are suitable for assessment by the National Institute for Health and Care Excellence (NICE), and whether they meet the criteria for the highly specialised technologies programme, are taken through an established topic selection process.</p><p>The process is overseen by NICE and includes consideration against published criteria by a topic selection panel and engagement with stakeholders. Although NHS England, NHS Improvement and the Department provide input and are part of this panel, the decision-making process is led by NICE. Kuvan for the treatment of phenylketonuria was last considered by the topic selection panel on 15 February 2019.</p><p>In the absence of guidance from NICE, it is for National Health Service organisations and healthcare professionals to make decisions on whether to fund Kuvan on the basis of an assessment of the available evidence. Treatment for patients with phenylketonuria who are not receiving Kuvan or for who Kuvan is not effective includes dietary protein restriction combined with dietary supplements.</p><p> </p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 06/08/2019 14:36:02 answering member 4380 label Biography information for Jo Churchill
	tabling member	1438 label Biography information for Mr Kevan Jones

1141362

	registered interest
	date	23/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Measles
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what guidance his Department has published on distinguishing between rashes caused by the measles vaccine and those arising from the wild strain of measles.
	tabling member constituency	Gravesham
	tabling member printed	Adam Holloway
	uin	280995
	answer	answer is ministerial correction date of answer 05/08/2019 answer text <p>While post vaccine rash and fever is generally mild, distinguishing from wild-type measles is not based on clinical examination, rather it is based on a combination of laboratory analysis, information on the timing of vaccine and epidemiological information. The national measles guidelines describe the management and investigation of suspected cases of measles, and is available to view at the following link:</p><p><a href="https://www.gov.uk/government/publications/national-measles-guidelines" target="_blank">https://www.gov.uk/government/publications/national-measles-guidelines</a></p><p>Statistics on confirmed measles cases are reported by vaccination status and are available at the following link:</p><p><a href="https://www.gov.uk/government/publications/measles-mumps-and-rubella-lab-confirmed-cases-in-england-2019" target="_blank">https://www.gov.uk/government/publications/measles-mumps-and-rubella-lab-confirmed-cases-in-england-2019</a></p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 280996 question first answered 05/08/2019 11:32:33 answering member 4380 label Biography information for Jo Churchill
	tabling member	1522 label Biography information for Adam Holloway

1141363

	registered interest
	date	23/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Measles
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that statistics on the infection rate for measles do not include people who have received the live measles vaccine and contracted a measles-like rash and fever.
	tabling member constituency	Gravesham
	tabling member printed	Adam Holloway
	uin	280996
	answer	answer is ministerial correction date of answer 05/08/2019 answer text <p>While post vaccine rash and fever is generally mild, distinguishing from wild-type measles is not based on clinical examination, rather it is based on a combination of laboratory analysis, information on the timing of vaccine and epidemiological information. The national measles guidelines describe the management and investigation of suspected cases of measles, and is available to view at the following link:</p><p><a href="https://www.gov.uk/government/publications/national-measles-guidelines" target="_blank">https://www.gov.uk/government/publications/national-measles-guidelines</a></p><p>Statistics on confirmed measles cases are reported by vaccination status and are available at the following link:</p><p><a href="https://www.gov.uk/government/publications/measles-mumps-and-rubella-lab-confirmed-cases-in-england-2019" target="_blank">https://www.gov.uk/government/publications/measles-mumps-and-rubella-lab-confirmed-cases-in-england-2019</a></p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 280995 question first answered 05/08/2019 11:32:33 answering member 4380 label Biography information for Jo Churchill
	tabling member	1522 label Biography information for Adam Holloway

1141364

	registered interest
	date	23/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	MMR Vaccine: Side Effects
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that (a) body inclusion encephalitis and (b) other adverse events experienced after a measles vaccine are identified in a timely way by healthcare professionals.
	tabling member constituency	Gravesham
	tabling member printed	Adam Holloway
	uin	280997
	answer	answer is ministerial correction date of answer 05/08/2019 answer text <p>The safety of all the United Kingdom’s vaccination programmes is of paramount importance. Any serious side effects are extremely rare, and the large majority of side effects are mild and transient, such as sore arms, headaches and tiredness. We would recommend that all eligible children are vaccinated, as any potential risk of side effects is far outweighed by the benefits of vaccination.</p><p>Healthcare professionals have access to a range of materials, such as ‘Immunisation against infectious disease: the green book’ and Patient Group Directions to support their decision-making in the case of any suspected adverse effects.</p><p>The Medicines and Healthcare products Regulatory Agency (MHRA) operates the ‘Yellow Card Scheme’, which is vital in helping the MHRA monitor the safety of all healthcare products in the UK. This system allows for reporting of any potential adverse events for all medicines, including vaccines, with guidance for healthcare professionals, patients and the public on how to use the scheme.</p><p>In addition, Public Health England (PHE) offers diagnostic services for suspected cases of encephalitis, which is a notifiable condition. Under statutory duty, cases must be reported by healthcare professionals to PHE’s local Health Protection Teams. This can be viewed at the following link:</p><p><a href="https://www.gov.uk/government/collections/notifications-of-infectious-diseases-noids" target="_blank">https://www.gov.uk/government/collections/notifications-of-infectious-diseases-noids</a></p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 05/08/2019 11:34:01 answering member 4380 label Biography information for Jo Churchill
	tabling member	1522 label Biography information for Adam Holloway